ImmuneSense COVID-19 Variant Study
Public ClinicalTrials.gov record NCT05054088. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ImmuneSense™ COVID-19 Variant Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the clinical performance of the T-Detect™ COVID test to identify an immune response to SARS-CoV-2 infection in the setting of multiple circulating variants of the SARS-CoV-2 virus. Performance may vary depending on the variants circulating at the time of testing, including newly emerging strains of SARS-CoV-2 and their prevalence, which changes over time.
Study identification
- NCT ID
- NCT05054088
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 203 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 89 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 12, 2021 (Actual)
- Primary completion
- Jul 20, 2022 (Actual)
- Completion
- Jul 28, 2022 (Actual)
- Last update posted
- Dec 7, 2022
2021 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Decentralized Trial Model- Phoenix | Phoenix | Arizona | 85001 | — |
| Decentralized Trial Model- Fullerton | Fullerton | California | 90621 | — |
| Decentralized Trial Model- California | Los Angeles | California | 90034 | — |
| Decentralized Trial Model- Modesto | Modesto | California | 95313 | — |
| Decentralized Trial Model- Sacramento | Sacramento | California | 94203 | — |
| Decentralized Trial Model- California | San Diego | California | 22400 | — |
| Decentralized Trial Model- San Francisco | San Francisco | California | 94016 | — |
| Decentralized Trial Model- Denver | Denver | Colorado | 80014 | — |
| Decentralized Trial Model - Washington D.C. | Washington D.C. | District of Columbia | 20001 | — |
| Decentralized Trial Model- Florida | Miami | Florida | 33101 | — |
| Decentralized Clinical Trial Model- New York City | New York | New York | 10001 | — |
| Decentralized Trial Model- Portland | Portland | Oregon | 97035 | — |
| Decentralized Trial Model- Utah | Salt Lake City | Utah | 84044 | — |
| Decentralized Trial Model- Seattle | Seattle | Washington | 98109 | — |
| Decentralized Trial Model- Vancouver, WA | Vancouver | Washington | 98607 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05054088, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 7, 2022 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05054088 live on ClinicalTrials.gov.